A detailed history of United Community Bank transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, United Community Bank holds 200 shares of XENE stock, worth $8,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Holding current value
$8,688
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$28.23 - $38.37 $5,646 - $7,673
200 New
200 $6.26 Million

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.7B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track United Community Bank Portfolio

Follow United Community Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Community Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Community Bank with notifications on news.